Year: 2019
Type: review
Abstract: Technological developments, including massively parallel DNA sequencing, gnotobiotics, metabolomics, RNA sequencing and culturomics, have markedly propelled the field of microbiome research in recent years. These methodologies can be harnessed to improve our in-depth mechanistic understanding of basic concepts related to consumption of probiotics, including their rules of engagement with the indigenous microbiome and impacts on the human host. We have recently demonstrated that even during probiotic supplementation, resident gut bacteria in a subset of individuals resist the mucosal presence of probiotic strains, limiting their modulatory effect on the microbiome and on the host gut transcriptional landscape. Resistance is partly alleviated by antibiotics treatment, which enables probiotics to interact with the host at the gut mucosal interface, although rather than promoting reconstitution of the indigenous microbiome and of the host transcriptional profile, they inhibit these components from returning to their naïve pre-antibiotic configurations. In this commentary, we discuss our findings in the context of previous and recent works, and suggest that incorporating the state-of-the-art methods currently utilized in microbiome research into the field of probiotics may lead to improved understanding of their mechanisms of activity, as well as their efficacy and long-term safety.
Source: Gut Microbes
Authors: Jotham Suez, Niv Zmora, Eran Elinav
Language: English
Subfield: Food Science
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,060
Funders: Gilead Sciences, Leona M. and Harry B. Helmsley Charitable Trust, Canadian Institute for Advanced Research, Gilead Research Scholars, European Foundation for the Study of Diabetes, Minerva Foundation, German-Israeli Foundation for Scientific Research and Development, Centre National de la Recherche Scientifique, Abisch-Frenkel-Stiftung, Rising Tide Foundation
OpenAlex ID: W2933023694
